Modulight Inc.

Laser manufacturer !%Modulight Inc.%! of Tampere, Finland, has designed, integrated and CE-certified an OEM medical laser system for PCI Biotech of Oslo, Norway, for a novel cancer therapy process. Under a multiyear agreement, Modulight will deliver a seven-channel medical laser system to the Norwegian company for its PCI (PhotoChemical Internalisation) patented photochemical drug delivery technology used for cancer therapy and other diseases. “The wavelength and the dose of the laser light in the treated tissue must be carefully controlled, requiring excellence in designing and building a stable laser system at our desired wavelength,” said Per Walday, CEO of PCI Biotech.